People | April 20, 2026
Novartis CEO Vas Narasimhan joins Anthropic board
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
The deal was executed via a merger of Novartis’ wholly owned subsidiary, Ajax Acquisition Sub, Inc., into Avidity
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
The acquisition will follow the planned separation of Avidity’s early-stage precision cardiology programs into a new, independent company
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Subscribe To Our Newsletter & Stay Updated
